hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang- 2022-04-12心理百科:春节期间小心疾病
- 2022-04-11北京癫痫手术费用
- 2022-04-112016AAN:神经专家发表了有前途的专业见解
- 2022-04-06癫痫治疗障碍仍难以克服
- 2022-04-05第四届全国临床脑电图实践基础理论与实践操作培训班
- 2022-04-04Radiology:利用MR颞叶癫痫病灶内侧指纹识别评价的价值
- 心理百科:春节期间小心疾病
- 北京癫痫手术费用
- 2016AAN:神经专家发表了有前途的专业见解
- 综述:癫痫持续状态诊治最新进展
- 癫痫治疗障碍仍难以克服
- 第四届全国临床脑电图实践基础理论与实践操作培训班
- Radiology:利用MR颞叶癫痫病灶内侧指纹识别评价的价值
- 北京哪家癫痫医院排名好,成本低
- 世界癫痫日 | 科学防治 标准诊疗 告别癫痫
- 三庚酸酯可治疗1型转运体缺陷综合征
- 癫痫会遗传吗 癫痫的治疗方法
- 什么是治疗癫痫 癫痫有这些偏方?
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 肺源性心脏病可能并发左心功能不全吗?如何制定治疗方案?
- 2015第31届国际癫痫大会(IEC)
- 癫痫患者手术评估新型工具
- Neurology:颅脑损伤增加了迟发性癫痫的风险,高损伤频率、重伤、老年人尤其是
- 控制癫痫患者再次抽搐,不包括可选药物?
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 38癫痫患者年病史上的感谢信 道出了浓浓的医患情况
- 英国竞争监管机构指控辉瑞癫痫药品价格过高
- 2013国际抗癫痫联合会抗癫痫药用指南
- 河南:无偿献血者用血费用一站式减免
- 2015 神经系统疾病诊疗进展
- 抗癫痫药物预防新发癫痫:任重而道远
- 睡觉时突然抽搐 新生儿睡觉抽搐怎么办?
- Diabetes Obes Metab:恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系
- 有利癫痫病治疗的日常习惯
- 黑芝麻的营养价值 吃黑芝麻的优点
- 小儿癫痫的更早症状 癫痫的原因
- 全省癫痫病治疗好医院
- 癫痫病的始自有什么症状
- 【用药问答】治疗哮喘大发作和局限性发作的药物?
- 癫痫病人的发病原因是什么
- Diabetologia:激活但功能受损的记忆Tregs在1型肝炎患者进展缓慢的过程中逐渐扩展
- 癫痫病频密发作怎么办
- 洋甘菊香草的沐浴法 洋甘菊香草能预防感冒
- 三庚酸酯或可治疗1型转运体缺点综合征
- 哪家癫痫病治疗最出色
- 癫痫病孕妇的病因与用药